Trial of Cyclosporine Inhalation Solution (CIS) in Lung transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans [Protocol Link]
Bronchiolitis obliterans is a lung disorder that can occur as a complication following bone marrow/blood stem cell transplantation. Researchers at the National Institute of Health (NIH) Clinical Center in Bethesda, Maryland, want to evaluate if inhaled cyclosporine can be used to improve or stabilize lung function in people with bronchiolitis obliterans.
One current treatment for bronchiolitis obliterans is taking cyclosporine by mouth as a pill. This study is evaluating if taking inhaled cyclosporine will provide a higher concentration of medication directly to the lungs and decrease the risk for side effects.
For more information, please contact the Office of Patient Recruitment at 1-800-411-1222 ext. TTY8664111010, or via email at PRPL@cc.nih.gov. Please reference study number 11-H-0068.